Acuta Sells Ocular Therapeutix Stake
Acuta Capital reduces its holdings in Ocular Therapeutix by 56% in Q1, potentially impacting the stock's performance. This sale may affect investor sentiment.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.